AFP and hepatocellular carcinoma: Non-B non-C HCC patients with a higher VATI (≥71 cm<sup>2</sup>/m<sup>2</sup>) or higher FIRI (≥5.5 μU/mL) and AFP (≥11 ng/mL) if VATI was <71 cm<sup>2</sup>/m<sup>2</sup> are prone to recurrence after curative treatment.